146 related articles for article (PubMed ID: 9040136)
1. MR imaging of musculoskeletal tumors and tumor mimickers with intravenous gadolinium: experience with 242 patients.
May DA; Good RB; Smith DK; Parsons TW
Skeletal Radiol; 1997 Jan; 26(1):2-15. PubMed ID: 9040136
[TBL] [Abstract][Full Text] [Related]
2. MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT.
Low RN; Francis IR
AJR Am J Roentgenol; 1997 Oct; 169(4):1051-9. PubMed ID: 9308464
[TBL] [Abstract][Full Text] [Related]
3. Musculoskeletal neoplasm: perineoplastic edema versus tumor on dynamic postcontrast MR images with spatial mapping of instantaneous enhancement rates.
Lang P; Honda G; Roberts T; Vahlensieck M; Johnston JO; Rosenau W; Mathur A; Peterfy C; Gooding CA; Genant HK
Radiology; 1995 Dec; 197(3):831-9. PubMed ID: 7480764
[TBL] [Abstract][Full Text] [Related]
4. MR imaging of musculoskeletal tumors of the hand and wrist.
Kransdorf MJ; Murphey MD
Magn Reson Imaging Clin N Am; 1995 May; 3(2):327-44. PubMed ID: 7553026
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT.
Low RN; Barone RM; Lacey C; Sigeti JS; Alzate GD; Sebrechts CP
Radiology; 1997 Aug; 204(2):513-20. PubMed ID: 9240546
[TBL] [Abstract][Full Text] [Related]
6. Benign and malignant musculoskeletal masses: MR imaging differentiation with rim-to-center differential enhancement ratios.
Ma LD; Frassica FJ; McCarthy EF; Bluemke DA; Zerhouni EA
Radiology; 1997 Mar; 202(3):739-44. PubMed ID: 9051028
[TBL] [Abstract][Full Text] [Related]
7. The role of fat-suppression technique and gadopentetate dimeglumine in magnetic resonance imaging evaluation of intraocular tumors and simulating lesions.
De Potter P; Flanders AE; Shields JA; Shields CL; Gonzales CF; Rao VM
Arch Ophthalmol; 1994 Mar; 112(3):340-8. PubMed ID: 8129659
[TBL] [Abstract][Full Text] [Related]
8. Musculoskeletal tumors: does fast dynamic contrast-enhanced subtraction MR imaging contribute to the characterization?
van der Woude HJ; Verstraete KL; Hogendoorn PC; Taminiau AH; Hermans J; Bloem JL
Radiology; 1998 Sep; 208(3):821-8. PubMed ID: 9722866
[TBL] [Abstract][Full Text] [Related]
9. Small pancreatic adenocarcinomas: efficacy of MR imaging with fat suppression and gadolinium enhancement.
Gabata T; Matsui O; Kadoya M; Yoshikawa J; Miyayama S; Takashima T; Nagakawa T; Kayahara M; Nonomura A
Radiology; 1994 Dec; 193(3):683-8. PubMed ID: 7972808
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
[TBL] [Abstract][Full Text] [Related]
11. The use of gadolinium in the MR imaging of bone tumors.
Sundaram M
Semin Ultrasound CT MR; 1997 Aug; 18(4):307-11. PubMed ID: 9285999
[TBL] [Abstract][Full Text] [Related]
12. MR imaging of edema accompanying benign and malignant bone tumors.
Kroon HM; Bloem JL; Holscher HC; van der Woude HJ; Reijnierse M; Taminiau AH
Skeletal Radiol; 1994 May; 23(4):261-9. PubMed ID: 8059251
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging of musculoskeletal lesions: comparison of three fat-saturation pulse sequences.
Pui MH; Goh PS; Choo HF; Fok EC
Australas Radiol; 1997 May; 41(2):99-102. PubMed ID: 9153802
[TBL] [Abstract][Full Text] [Related]
14. MRI in the investigation of Morton's neuroma: which sequences?
Williams JW; Meaney J; Whitehouse GH; Klenerman L; Hussein Z
Clin Radiol; 1997 Jan; 52(1):46-9. PubMed ID: 9022580
[TBL] [Abstract][Full Text] [Related]
15. Is it necessary to routinely use gadolinium in the MR imaging evaluation of soft-tissue tumors of the extremities?
Kransdorf MJ
AJR Am J Roentgenol; 1995 Dec; 165(6):1545. PubMed ID: 7484606
[No Abstract] [Full Text] [Related]
16. Bladder tumor staging: comparison of conventional and gadolinium-enhanced dynamic MR imaging and CT.
Tanimoto A; Yuasa Y; Imai Y; Izutsu M; Hiramatsu K; Tachibana M; Tazaki H
Radiology; 1992 Dec; 185(3):741-7. PubMed ID: 1438756
[TBL] [Abstract][Full Text] [Related]
17. Characterization of focal hepatic masses by dynamic contrast-enhanced MR imaging: findings in 311 lesions.
Quillin SP; Atilla S; Brown JJ; Borrello JA; Yu CY; Pilgram TK
Magn Reson Imaging; 1997; 15(3):275-85. PubMed ID: 9201674
[TBL] [Abstract][Full Text] [Related]
18. Osteosarcoma after chemotherapy: evaluation with contrast material-enhanced subtraction MR imaging.
de Baere T; Vanel D; Shapeero LG; Charpentier A; Terrier P; di Paola M
Radiology; 1992 Nov; 185(2):587-92. PubMed ID: 1410378
[TBL] [Abstract][Full Text] [Related]
19. Dynamic contrast-enhanced subtraction versus T2-weighted spin-echo MR imaging in the follow-up of colorectal neoplasm: a prospective study of 41 patients.
Kinkel K; Tardivon AA; Soyer P; Spatz A; Lasser P; Rougier P; Vanel D
Radiology; 1996 Aug; 200(2):453-8. PubMed ID: 8685341
[TBL] [Abstract][Full Text] [Related]
20. Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results.
Jager GJ; Ruijter ET; van de Kaa CA; de la Rosette JJ; Oosterhof GO; Thornbury JR; Ruijs SH; Barentsz JO
Radiology; 1997 Jun; 203(3):645-52. PubMed ID: 9169683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
